Join this webinar if you want to learn about:
- Integration rapifleX in uHTS
- How to setup MALDI assays for screening (tips & tricks)
- Improved hit finding using MS-technology
- Performing uHTS screens using rapifleX
In this session we will focus on label-free mass spectrometry technology
Pivot Park Screening Centre (PPSC) will present the integration and the first successful campaign of over 0.5 million compounds using label-free mass spectrometry technology. The rapifleX Maldi PharmaPulse MPP® (Bruker) and CyBio® Well Vario pipettor (Analytik Jena) are fully integrated in the robotic platform at PPSC. This revolutionary hit finding technology combined with automated sample-matrix spotter enables screening of large compound libraries in 1536-well format. Direct quantification of reaction product(s) without the need for fluorescent labels using the rapifleX MPP® improves the quality of uHTS output, reducing the likelihood of false positive and negative datapoints and facilitating a more time- and cost-effective hit-to-lead phase.
- Integration rapifleX in uHTS
- How to setup MALDI assays for screening (tips & tricks)
- Improved hit finding using MS-technology
- Performing uHTS screens using rapifleX
In this session we will focus on label-free mass spectrometry technology
Pivot Park Screening Centre (PPSC) will present the integration and the first successful campaign of over 0.5 million compounds using label-free mass spectrometry technology. The rapifleX Maldi PharmaPulse MPP® (Bruker) and CyBio® Well Vario pipettor (Analytik Jena) are fully integrated in the robotic platform at PPSC. This revolutionary hit finding technology combined with automated sample-matrix spotter enables screening of large compound libraries in 1536-well format. Direct quantification of reaction product(s) without the need for fluorescent labels using the rapifleX MPP® improves the quality of uHTS output, reducing the likelihood of false positive and negative datapoints and facilitating a more time- and cost-effective hit-to-lead phase.
